Webcast:

The right antibiotic: potential clinical outcomes and the hidden risks of a low-cost therapy

Alt tag

Webcast:

The right antibiotic: potential clinical outcomes and the hidden risks of a low-cost therapy

About this webcast

In the prescribing of antibiotics, generic agents are often favoured over original products because of their lower cost, but there is much more to consider than just the price difference.

Speakers

Emeritus professor

Professor Paul M Tulkens

Emeritus professor

Université catholique de Louvain, Belgium

Paul M Tulkens is Emeritus Professor at the Université catholique de Louvain, Belgium. He founded and until 2003 was head of the University’s Cellular and Molecular Pharmacology Unit in the Louvain Drug Research Institute where he continues his research.

If you have observed any unwanted or adverse effect, or have a quality complaint related to a Bayer product, we would be interested to hear about it as part of our ongoing pharmacovigilance processes. You may report these to us through our Bayer Side Effect Reporting website.